AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11731184 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination group
Number of subjects: 202
Study 11731184 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination regimen
Number of subjects: 202
Study 11731184 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitonin treatment
Number of subjects: 202
Study 9789699 — intervention group
Group type: EXPERIMENTAL
Intervention: Procainamide (100 mg i.v. bolus every 5 min up to 1 g)
Number of subjects: 117
Study 9789699 — intervention group
Group type: COMPARATOR
Intervention: Propafenone (2 mg/kg body weight i.v. over 30 min)
Number of subjects: 117
Study 7633974 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine 3 micrograms/kg/min
Number of subjects: 30
Study 7633974 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 2585215 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K1 (5 mg intramuscularly)
Number of subjects: 14
Study 2585215 — intervention group
Group type: COMPARATOR
Intervention: Control (no vitamin K1)
Number of subjects: 14
Study 793777 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg amitriptyline as 3 daytime doses
Number of subjects: 41
Study 793777 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg amitriptyline as a single dose at bedtime
Number of subjects: 41
Study 31105976 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal glyceryl trinitrate (GTN)
Number of subjects: 2023
Study 31105976 — intervention group
Group type: COMPARATOR
Intervention: No GTN
Number of subjects: 2023
Study 31105976 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuing prestroke antihypertensives
Number of subjects: 2023
Study 31105976 — intervention group
Group type: COMPARATOR
Intervention: Stopping prestroke antihypertensives
Number of subjects: 2023
Study 28809637 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment using plate osteosynthesis (LCP Distal Ulna Plate) for proximal third ulnar styloid process fractures, ulnar head fractures, and subcapital fractures.
Number of subjects: 81
Study 28809637 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative treatment for tip fractures of ulnar styloid process.
Number of subjects: 81
Study 28809637 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment for ulnar base fractures.
Number of subjects: 81
Study 28809637 — intervention group
Group type: COMPARATOR
Intervention: Operative treatment for subcapital ulnar fractures.
Number of subjects: 81
Study 28809637 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment for ulnar head fractures.
Number of subjects: 81
Study 25661658 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT)
Number of subjects: 60
Study 25661658 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 24529671 — intervention group
Group type: EXPERIMENTAL
Intervention: bupivacaine 10 mg combined with 0.1 mg/kg ketamine
Number of subjects: 60
Study 24529671 — intervention group
Group type: COMPARATOR
Intervention: bupivacaine 10 mg combined with 0.5 mL distilled water
Number of subjects: 60
Study 21492183 — intervention group
Group type: EXPERIMENTAL
Intervention: Single platelet units (SPUs)
Number of subjects: 18
Study 21492183 — intervention group
Group type: EXPERIMENTAL
Intervention: Double platelet units (DPUs)
Number of subjects: 18
Study 21492183 — intervention group
Group type: EXPERIMENTAL
Intervention: Storage of PBMCs in autologous plasma in PVC‐bags at room temperature
Number of subjects: 18
Study 19321651 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa (L-DOPA)
Number of subjects: 20
Study 19321651 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 18005303 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic searching of the Polish Medical Bibliography
Number of subjects: 680
Study 15554471 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery audio tape intervention
Number of subjects: 13
Study 15554471 — intervention group
Group type: COMPARATOR
Intervention: Usual care and a music audio tape
Number of subjects: 13
Study 11207083 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic analysis of the QT interval
Number of subjects: 0
Study 9444592 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-strength oxidizing lozenge
Number of subjects: 123
Study 9444592 — intervention group
Group type: COMPARATOR
Intervention: Breath mints
Number of subjects: 123
Study 9444592 — intervention group
Group type: COMPARATOR
Intervention: Chewing gum with no active ingredients
Number of subjects: 123
Study 9444592 — intervention group
Group type: COMPARATOR
Intervention: Regular oxidizing lozenge
Number of subjects: 123
Study 9444592 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 123
Study 7920310 — intervention group
Group type: EXPERIMENTAL
Intervention: ganciclovir
Number of subjects: 25
Study 7920310 — intervention group
Group type: EXPERIMENTAL
Intervention: foscarnet
Number of subjects: 25
Study 3284282 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency contracting for medication take-home privileges
Number of subjects: 40
Study 3284282 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency contracting targeting non-cocaine drugs
Number of subjects: 40
Study 3284282 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-drug-related contracts
Number of subjects: 40
Study 3284282 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency contracting
Number of subjects: 40
Study 31465756 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise therapy plus dry needling (Ex+DN group)
Number of subjects: 40
Study 31465756 — intervention group
Group type: COMPARATOR
Intervention: Exercise therapy (Ex group)
Number of subjects: 40
Study 31242937 — intervention group
Group type: EXPERIMENTAL
Intervention: CIPEXERCISE (hand exercise program)
Number of subjects: 55
Study 31242937 — intervention group
Group type: COMPARATOR
Intervention: CIPCONTROL (compensatory intervention only)
Number of subjects: 55
Study 31242937 — intervention group
Group type: EXPERIMENTAL
Intervention: CIPEXERCISE
Number of subjects: 55
Study 31242937 — intervention group
Group type: COMPARATOR
Intervention: CIPCONTROL
Number of subjects: 55
Study 27334604 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical anesthesia (group 1, n=76)
Number of subjects: 157
Study 27334604 — intervention group
Group type: COMPARATOR
Intervention: Retrobulbar anesthesia (group 2, n=81)
Number of subjects: 157
Study 27334604 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall pain and discomfort scores
Number of subjects: 157
Study 27334604 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgeon comfort scores
Number of subjects: 157
Study 27334604 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional anesthesia or sedation
Number of subjects: 157
Study 26059102 — intervention group
Group type: EXPERIMENTAL
Intervention: Methanocalculus‐specific TaqMan qPCR assay
Number of subjects: 0
Study 26059102 — intervention group
Group type: EXPERIMENTAL
Intervention: Formate as the substrate
Number of subjects: 0
Study 26059102 — intervention group
Group type: EXPERIMENTAL
Intervention: Field application of the qPCR assay
Number of subjects: 0
Study 23274148 — intervention group
Group type: EXPERIMENTAL
Intervention: SBS-QoL™ scale
Number of subjects: 0
Study 21611981 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin enacarbil 1200 mg once daily
Number of subjects: 136
Study 21611981 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study 18465136 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 62
Study 18465136 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 62
Study 17380212 — intervention group
Group type: EXPERIMENTAL
Intervention: Mecasermin rinfabate
Number of subjects: 0
Study 17380212 — intervention group
Group type: COMPARATOR
Intervention: Unbound recombinant human IGF‐I (rhIGF‐I)
Number of subjects: 0
Study 15159270 — intervention group
Group type: EXPERIMENTAL
Intervention: niacin ER/lovastatin (1500/20 mg)
Number of subjects: 164
Study 15159270 — intervention group
Group type: EXPERIMENTAL
Intervention: niacin ER/lovastatin (2000/40 mg)
Number of subjects: 164
Study 15159270 — intervention group
Group type: EXPERIMENTAL
Intervention: niacin ER (each 500 mg increase)
Number of subjects: 164
Study 15159270 — intervention group
Group type: EXPERIMENTAL
Intervention: niacin ER/lovastatin (2000/40 mg/d)
Number of subjects: 164
Study 11684748 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 157
Study 11684748 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 157
Study 11684748 — intervention group
Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 157
Study 11684748 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 157
Study 9737476 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin (1 mg/kg twice daily subcutaneously)
Number of subjects: 3171
Study 9737476 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin (continuous intravenous)
Number of subjects: 3171
Study 7887165 — intervention group
Group type: EXPERIMENTAL
Intervention: Local specific immunotherapy plus sodium cromoglycate
Number of subjects: 40
Study 7887165 — intervention group
Group type: COMPARATOR
Intervention: Sodium cromoglycate and saline solution
Number of subjects: 40
Study 3580432 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 mg RS 86
Number of subjects: 12
Study 3580432 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.0 mg RS 86
Number of subjects: 12
Study 30875669 — intervention group
Group type: EXPERIMENTAL
Intervention: NEW Tx (Nutrition Exercise and Wellness Treatment)
Number of subjects: 38
Study 30875669 — intervention group
Group type: COMPARATOR
Intervention: Control (treatment as usual waitlist)
Number of subjects: 38
Study 28527047 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary ascorbic acid (50 mg/kg)
Number of subjects: 0
Study 28527047 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary ascorbic acid (100 mg/kg)
Number of subjects: 0
Study 28527047 — intervention group
Group type: COMPARATOR
Intervention: Control (1.30% effluent without ascorbic acid)
Number of subjects: 0
Study 26923336 — intervention group
Group type: EXPERIMENTAL
Intervention: High serum levels of DHEAS (highest tertile) in males
Number of subjects: 1258
Study 26923336 — intervention group
Group type: COMPARATOR
Intervention: Lower serum levels of DHEAS (reference group) in males
Number of subjects: 1258
Study 26923336 — intervention group
Group type: EXPERIMENTAL
Intervention: High serum levels of DHEAS (highest tertile) in females
Number of subjects: 1258
Study 26923336 — intervention group
Group type: COMPARATOR
Intervention: Lower serum levels of DHEAS (reference group) in females
Number of subjects: 1258
Study 24615602 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive video-assisted thyroidectomy (MIVAT)
Number of subjects: 62
Study 24615602 — intervention group
Group type: COMPARATOR
Intervention: Robot-assisted transaxillary thyroidectomy (RATT)
Number of subjects: 62
Study 22248536 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-load condition
Number of subjects: 0
Study 22248536 — intervention group
Group type: EXPERIMENTAL
Intervention: High-load condition
Number of subjects: 0
Study 22248536 — intervention group
Group type: EXPERIMENTAL
Intervention: Valid trials
Number of subjects: 0
Study 22248536 — intervention group
Group type: EXPERIMENTAL
Intervention: High perceptual load condition
Number of subjects: 0
Study 22248536 — intervention group
Group type: COMPARATOR
Intervention: Invalid trials
Number of subjects: 0
Study 18562788 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent training (2 sessions per week for 8 months)
Number of subjects: 57
Study 18562788 — intervention group
Group type: EXPERIMENTAL
Intervention: Detraining (3 months after training)
Number of subjects: 57
Study 18562788 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 57
Study 17335363 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioactive ceramic filler
Number of subjects: 19
Study 17335363 — intervention group
Group type: COMPARATOR
Intervention: Control (open debridement alone)
Number of subjects: 19
Study 15593456 — intervention group
Group type: EXPERIMENTAL
Intervention: Pylorus-preserving gastrectomy (PPG)
Number of subjects: 81
Study 15593456 — intervention group
Group type: COMPARATOR
Intervention: Conventional distal gastrectomy (CDG)
Number of subjects: 81
Study 11449084 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 116
Study 11449084 — intervention group
Group type: COMPARATOR
Intervention: Untreated women
Number of subjects: 116
Study 9544237 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous gamma globulin (IVIG) therapy
Number of subjects: 7
Study 9544237 — intervention group
Group type: COMPARATOR
Intervention: Matched pediatric control patients (PCC)
Number of subjects: 7
Study 9544237 — intervention group
Group type: COMPARATOR
Intervention: Parents of KD patients
Number of subjects: 7
Study 7541325 — intervention group
Group type: EXPERIMENTAL
Intervention: rhG-CSF (Granulocyte Injection) with chemotherapy
Number of subjects: 22
Study 7541325 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 22
Study 2905239 — intervention group
Group type: EXPERIMENTAL
Intervention: Roxatidine acetate 75 mg twice daily
Number of subjects: 700
Study 2905239 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine 200 mg four times daily
Number of subjects: 700
Study 31771895 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostate Artery Embolization (PAE)
Number of subjects: 0
Study 30239116 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate exercise (IMEX, n=54)
Number of subjects: 104
Study 30239116 — intervention group
Group type: COMPARATOR
Intervention: Delayed exercise (DEL, n=50)
Number of subjects: 104
Study 30239116 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate exercise (IMEX)
Number of subjects: 104
Study 30239116 — intervention group
Group type: COMPARATOR
Intervention: Delayed exercise (DEL)
Number of subjects: 104
Study 27243350 — intervention group
Group type: EXPERIMENTAL
Intervention: ACUVUE OASYS for Presbyopia
Number of subjects: 55
Study 27243350 — intervention group
Group type: EXPERIMENTAL
Intervention: AIR OPTIX AQUA Multifocal
Number of subjects: 55
Study 27243350 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial fitting
Number of subjects: 55
Study 27243350 — intervention group
Group type: EXPERIMENTAL
Intervention: Acuity-based measures
Number of subjects: 55
Study 25886844 — intervention group
Group type: EXPERIMENTAL
Intervention: HIRT HEMS
Number of subjects: 505
Study 25886844 — intervention group
Group type: COMPARATOR
Intervention: GSA HEMS
Number of subjects: 505
Study 24011382 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction of labour (IOL)
Number of subjects: 201
Study 24011382 — intervention group
Group type: COMPARATOR
Intervention: Expectant monitoring (EM)
Number of subjects: 201
Study 21383109 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive strategy instruction based on PASS for 10 days
Number of subjects: 0
Study 21383109 — intervention group
Group type: COMPARATOR
Intervention: Standard math instruction (Control)
Number of subjects: 0
Study 19286143 — intervention group
Group type: COMPARATOR
Intervention: Burch colposuspension
Number of subjects: 655
Study 19286143 — intervention group
Group type: COMPARATOR
Intervention: Sling surgery
Number of subjects: 655
Study 19286143 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful surgery
Number of subjects: 655
Study 19286143 — intervention group
Group type: COMPARATOR
Intervention: Incontinence
Number of subjects: 655
Study 19286143 — intervention group
Group type: COMPARATOR
Intervention: Fear of incontinence
Number of subjects: 655
Study 19286143 — intervention group
Group type: COMPARATOR
Intervention: Vaginal bulging
Number of subjects: 655
Study 19286143 — intervention group
Group type: COMPARATOR
Intervention: Negative emotional reactions during sex
Number of subjects: 655
Study 17407633 — intervention group
Group type: EXPERIMENTAL
Intervention: EZE + ATV (Ezetimibe 10 mg + Atorvastatin 10 mg)
Number of subjects: 148
Study 17407633 — intervention group
Group type: COMPARATOR
Intervention: ATV (Atorvastatin 10 mg)
Number of subjects: 148
Study 17407633 — intervention group
Group type: EXPERIMENTAL
Intervention: EZE + ATV
Number of subjects: 148
Study 17407633 — intervention group
Group type: COMPARATOR
Intervention: ATV
Number of subjects: 148
Study 17407633 — intervention group
Group type: EXPERIMENTAL
Intervention: EZE + ATV and ATV
Number of subjects: 148
Study 15351413 — intervention group
Group type: EXPERIMENTAL
Intervention: St. Georg Sled (fixed bearing UKR)
Number of subjects: 91
Study 15351413 — intervention group
Group type: COMPARATOR
Intervention: Oxford mobile bearing UKR
Number of subjects: 91
Study 11095203 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycolic acid peels (20%, 35%, 50%, and 70% concentrations) applied serially at 2-week intervals to 23 patients in Group A
Number of subjects: 58
Study 11095203 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% glycolic acid cream used once or twice daily for 24 weeks by 20 patients in Group B
Number of subjects: 58
Study 11095203 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream applied twice daily for 24 weeks by 15 patients in Group C
Number of subjects: 58
Study 9506004 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (5 mg/kg anhydrous, oral administration)
Number of subjects: 7
Study 9506004 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 9506004 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 7
Study 9506004 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline and Placebo
Number of subjects: 7
Study 8456071 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-disintegrating vitamin C tablet (8-9 min)
Number of subjects: 15
Study 8456071 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C tablet with a mean disintegration time of 60 min
Number of subjects: 15
Study 8456071 — intervention group
Group type: COMPARATOR
Intervention: Standard vitamin C solution
Number of subjects: 15
Study 2416520 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine treatment (1 g/day) for four weeks (standard treatment group)
Number of subjects: 75
Study 2416520 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine treatment (1 g/day) for a minimum of one week and thereafter until symptoms controlled (symptomatic treatment group)
Number of subjects: 75
Study 2416520 — intervention group
Group type: COMPARATOR
Intervention: Both treatment regimens (standard and symptomatic)
Number of subjects: 75
Study 2416520 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptomatic treatment group
Number of subjects: 75
Study 2416520 — intervention group
Group type: COMPARATOR
Intervention: Patients with unhealed ulcers
Number of subjects: 75
Study 31033669 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional experience in the prevention and control of HIV, other sexually transmitted infections, or other infectious diseases
Number of subjects: 76
Study 31033669 — intervention group
Group type: EXPERIMENTAL
Intervention: Working at MMT clinics affiliated with Center for Disease Control and Prevention sites
Number of subjects: 76
Study 31033669 — intervention group
Group type: EXPERIMENTAL
Intervention: Perception of greater institutional support
Number of subjects: 76
Study 28922046 — intervention group
Group type: EXPERIMENTAL
Intervention: Supraorbital electrical stimulation (SOES) in addition to conventional physical therapy (20 minutes daily for 8 weeks)
Number of subjects: 45
Study 28922046 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional physical therapy (3 times a week for 8 weeks)
Number of subjects: 45
Study 28922046 — intervention group
Group type: COMPARATOR
Intervention: Prescribed medications only
Number of subjects: 45
Study 26271817 — intervention group
Group type: EXPERIMENTAL
Intervention: History of childhood sexual and/or physical abuse (CSA and/or CPA) among men
Number of subjects: 0
Study 26271817 — intervention group
Group type: EXPERIMENTAL
Intervention: History of childhood sexual and/or physical abuse (CSA and/or CPA) among women
Number of subjects: 0
Study 26271817 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with histories of CSA and/or CPA
Number of subjects: 0
Study 25083090 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback-guided pelvic floor exercise therapy (BFT)
Number of subjects: 88
Study 25083090 — intervention group
Group type: COMPARATOR
Intervention: Oral polyethylene glycol (PEG)
Number of subjects: 88
Study 22137497 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal testosterone (300 μg daily)
Number of subjects: 51
Study 22137497 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 51
Study 20738745 — intervention group
Group type: EXPERIMENTAL
Intervention: Nighttime home monitoring system
Number of subjects: 49
Study 20738745 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 49
Study 18260178 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K2 alone (Group K)
Number of subjects: 79
Study 18260178 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K2 plus etidronate (Group KE)
Number of subjects: 79
Study 18260178 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K2 plus risedronate (Group KR)
Number of subjects: 79
Study 18260178 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 79
Study 15781540 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2% plus clonidine 2 microg/mL
Number of subjects: 20
Study 15781540 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine 0.2%
Number of subjects: 20
Study 14519752 — intervention group
Group type: EXPERIMENTAL
Intervention: Screened arm (prostate-specific antigen, digital rectal and transrectal ultrasound examinations)
Number of subjects: 17226
Study 14519752 — intervention group
Group type: COMPARATOR
Intervention: Control arm (no screening)
Number of subjects: 17226
Study 14519752 — intervention group
Group type: EXPERIMENTAL
Intervention: Screened arm (considering all interval cancers)
Number of subjects: 17226
Study 14519752 — intervention group
Group type: EXPERIMENTAL
Intervention: Screened arm (considering only cancers classified as T1A-C or T2A)
Number of subjects: 17226
Study 11078536 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadriceps tendon (QT) tibial tunnel interference fixation
Number of subjects: 10
Study 11078536 — intervention group
Group type: EXPERIMENTAL
Intervention: EndoButton femoral fixation
Number of subjects: 10